These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 28315425)
1. The expression of a tumor suppressor gene JDP2 and its prognostic value in hepatocellular carcinoma patients. Chen YL; Chan SH; Lin PY; Chu PY Hum Pathol; 2017 May; 63():212-216. PubMed ID: 28315425 [TBL] [Abstract][Full Text] [Related]
2. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer. Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339 [TBL] [Abstract][Full Text] [Related]
3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
4. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma. Pan LH; Yao M; Cai Y; Gu JJ; Yang XL; Wang L; Yao DF World J Gastroenterol; 2016 Apr; 22(14):3829-36. PubMed ID: 27076768 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma. Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391 [TBL] [Abstract][Full Text] [Related]
6. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma. Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587 [TBL] [Abstract][Full Text] [Related]
7. RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma. Zhang J; Jiang TY; Jiang BG; Yang C; Tan YX; Yang N; Pan YF; Ding ZW; Yang GZ; Wu MC; Dong LW; Wang HY Oncotarget; 2015 Feb; 6(5):3432-42. PubMed ID: 25605019 [TBL] [Abstract][Full Text] [Related]
8. KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. Schmid K; Wang X; Haitel A; Sieghart W; Peck-Radosavljevic M; Bodingbauer M; Rasoul-Rockenschaub S; Wrba F Virchows Arch; 2007 Feb; 450(2):143-9. PubMed ID: 17216189 [TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma. Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439 [TBL] [Abstract][Full Text] [Related]
10. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. Yin F; Han X; Yao SK; Wang XL; Yang HC World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422 [TBL] [Abstract][Full Text] [Related]
11. Characterization of somatostatin receptor 2 and 5 expression in operable hepatocellular carcinomas. Li S; Liu Y; Shen Z Hepatogastroenterology; 2012 Oct; 59(119):2054-8. PubMed ID: 22640914 [TBL] [Abstract][Full Text] [Related]
12. Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma. Sun C; Huang S; Ju W; Hou Y; Wang Z; Liu Y; Wu L; He X Hum Pathol; 2018 Nov; 81():113-120. PubMed ID: 30136646 [TBL] [Abstract][Full Text] [Related]
13. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma. Wang L; Yao M; Fang M; Zheng WJ; Dong ZZ; Pan LH; Zhang HJ; Yao DF Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):227-232. PubMed ID: 29709351 [TBL] [Abstract][Full Text] [Related]
14. The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice. Bitton-Worms K; Pikarsky E; Aronheim A Mol Cancer; 2010 Mar; 9():54. PubMed ID: 20214788 [TBL] [Abstract][Full Text] [Related]
15. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma. Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813 [TBL] [Abstract][Full Text] [Related]
16. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation. Li H; Wang S; Wang G; Zhang Z; Wu X; Zhang T; Fu B; Chen G Dig Surg; 2014; 31(6):468-78. PubMed ID: 25632982 [TBL] [Abstract][Full Text] [Related]
17. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification. Zhang Y; Fan Y; Mei Z Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279 [TBL] [Abstract][Full Text] [Related]